4//SEC Filing
Hanley Jr. Michael Conick 4
Accession 0001567619-19-019922
CIK 0001636282other
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 4:09 PM ET
Size
5.6 KB
Accession
0001567619-19-019922
Insider Transaction Report
Form 4
Hanley Jr. Michael Conick
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-10-21+130,000→ 130,000 totalExercise: $7.79Exp: 2029-10-20→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]The options will vest as to 1/4th of the total shares on October 21, 2020, and then 1/48th of the shares monthly thereafter, such that the option is fully vested on October 21, 2023, subject to the Reporting Person's provision of service to the issuer on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001791413
Filing Metadata
- Form type
- 4
- Filed
- Oct 22, 8:00 PM ET
- Accepted
- Oct 23, 4:09 PM ET
- Size
- 5.6 KB